“…In addition, the aforementioned resulting products also suffered from poor site selectivity at the two NH units with pyrido‐benzodiazepine for further N‐functionalization (Scheme , pathway 1). To overcome above disadvantage in pathway 1 caused by ortho ‐phenyldiamine, various coupling partners, such as ortho ‐nitroaniline, 2‐chloropyridin‐3‐amine, 2‐aminobenzoic acid, methyl 2‐aminobenzoate, 2‐bromobenzamide, as well as three‐component systems, have been used to displace the ortho ‐phenyldiamine for the synthesis of pyrido‐benzodiazepine compounds, with a focus on achieving high selectivity (Scheme , pathway 2).…”